Health Trials

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

ConditionGrowth Hormone Deficiency
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAscendis Pharma Endocrinology Division A/S

About this trial

The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care

Eligibility criteria

Qualifiers

Patients who are on treatment with SKYTROFA (lonapegsomatropin)

Patients being clinically managed in USA

Patients with an appropriate written informed consent/assent as applicable for the age of the patient

Disqualifiers

Patients participating in any interventional clinical study

Trial design

Treatments tested in this trial

  • No intervention

Treatment groups

900 Participants
are divided into 1 treatment group

Sponsors and collaborators

Ascendis Pharma Endocrinology Division A/S

Lead sponsor

Source ClinicalTrials.gov